Fig. 9From: Discovery of dual rho-associated protein kinase 1 (ROCK1)/apoptosis signal–regulating kinase 1 (ASK1) inhibitors as a novel approach for non-alcoholic steatohepatitis (NASH) treatmentClassification of the 407 docked molecules based on their molecular docking results at the binding sites of the target kinases ROCK1 and ASK1Back to article page